ARTICLE | Financial News
Aslan approved for Taipei listing
January 24, 2017 12:43 AM UTC
Aslan Pharmaceuticals Ltd. (Singapore) said it has been approved to list on Taiwan's Taipei Exchange.
Founded in 2010, Aslan aims to acquire rights to molecules from pharmas, develop the candidates in Asia through proof-of-concept, and return each Phase III-ready compound to its originator or find another partner...